- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- CNNMoney sits down with Walgreens chief to discuss future of health care and what it means for pharmacy
- Walgreens, Rite Aid join outcry over Boston Rolling Stone cover
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
CHICAGO — Standard & Poor's cut its outlook on Walgreens to negative from stable, citing the lack of progress in the drug store chain's negotiations with Express Scripts, according to a MarketWatch report published Thursday.
S&P noted that the loss of the Express Scripts contract will result in a meaningful revenue and profit decline in fiscal 2012 in initiating its outlook adjustment.
However, S&P did affirm its ratings on the company, including an 'A' corporate credit rating, MarketWatch reported.
Shares of Walgreens were down 18 cents to $32.97 in mid-morning trading.